Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

University of Bonn

Headquarters: Bonn, Germany
Year Founded: 1818
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Jul 31, 2020
Distillery Therapeutics

ADORA2B agonism for obesity and aging-induced sarcopenia

BioCentury | Jan 31, 2020
Distillery Therapeutics

Inhibiting SPK2 to treat Middle East respiratory syndrome

BioCentury | Jul 20, 2018
Financial News

IFM launches subsidiary with $31M series A

BioCentury | Jul 19, 2018
Financial News

IFM launches subsidiary with $31M series A

BioCentury | Feb 21, 2018
Distillery Techniques

Drug delivery

BioCentury | Jan 19, 2018
Strategy

After amyloid

How the Alzheimer’s disease community is moving past amyloid
BioCentury | Jan 4, 2018
Distillery Therapeutics

Neurology

BioCentury | Dec 22, 2017
Preclinical News

New inflammasome target for early intervention in AD

BioCentury | Nov 15, 2017
Distillery Therapeutics

Cancer

Items per page:
1 - 10 of 67